VX-853
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VX-853, covering 2011-03-24 to 2011-03-24. Get the full timeline:
Most recent: Clinical Trial Update: VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin [Phase 1, Phase 2]